Related Experiment Video
Updated: Dec 1, 2025

A 3D Spheroid Model for Glioblastoma
Published on: April 9, 2020
SPOCK1: a multi-domain proteoglycan at the crossroads of extracellular matrix remodeling and cancer development
1Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310003, China.
Abstract:
The SPARC/osteonectin, CWCV and Kazal-like domains proteoglycan 1 (SPOCK1) is a highly conserved, multi-domain proteoglycan that regulates the dynamic equilibrium of extracellular matrix (ECM). Besides, SPOCK1 is one of the key regulatory genes in the tumor ECM dynamic homeostasis process, which activates many molecular signaling pathways (such as EMT process, Wnt/β-catenin, PI3K/Akt, and mTOR/S6K signaling pathways). This activation leads to ECM remodeling and promotes cell proliferation and invasion, but inhibits cell apoptosis. Whereas there is immense information about SPOCK1's roles in different biological settings, there is need for further studies that interrogate this protein as a potential therapeutic target in cancer.
Insights
SPOCK1, a proteoglycan regulating extracellular matrix, is a key player in tumor progression. Further research is needed to explore SPOCK1 as a potential cancer therapeutic target.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Biology
Background:
- SPOCK1 (SPARC/osteonectin, CWCV and Kazal-like domains proteoglycan 1) is a conserved proteoglycan crucial for extracellular matrix (ECM) homeostasis.
- SPOCK1 plays a significant role in tumor ECM dynamic homeostasis, influencing key signaling pathways.
- Dysregulation of SPOCK1 is implicated in promoting tumor progression by affecting cell proliferation, invasion, and apoptosis.
Purpose of the Study:
- To highlight the multifaceted roles of SPOCK1 in biological processes.
- To emphasize the need for further investigation into SPOCK1's therapeutic potential in cancer.
Main Methods:
- Literature review and analysis of existing data on SPOCK1 functions.
- Exploration of SPOCK1's involvement in molecular signaling pathways (EMT, Wnt/β-catenin, PI3K/Akt, mTOR/S6K).
Main Results:
- SPOCK1 activation leads to ECM remodeling.
- SPOCK1 promotes cancer cell proliferation and invasion.
- SPOCK1 inhibits cancer cell apoptosis.
Conclusions:
- SPOCK1 is a critical regulator of tumor microenvironment and cancer progression.
- SPOCK1 represents a promising therapeutic target for cancer treatment.
More Related Videos
Related Concept Videos
Matrix Proteoglycans and Glycoproteins
Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Extracellular Matrix
Proteoglycans
Role of Matrix Metalloproteases in Degradation of ECM

